Annual SG&A:
$359.27M+$64.13M(+21.73%)Summary
- As of today, BPMC annual SG&A is $359.27 million, with the most recent change of +$64.13 million (+21.73%) on December 31, 2024.
- During the last 3 years, BPMC annual SG&A has risen by +$163.98 million (+83.97%).
Performance
BPMC SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
Quarterly SG&A:
$95.81M-$643.00K(-0.67%)Summary
- As of today, BPMC quarterly SG&A is $95.81 million, with the most recent change of -$643.00 thousand (-0.67%) on March 31, 2025.
- Over the past year, BPMC quarterly SG&A has increased by +$12.25 million (+14.66%).
Performance
BPMC Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
TTM SG&A:
-$9.47B-$155.73M(-1.67%)Summary
- As of today, BPMC TTM SG&A is -$9.47 billion, with the most recent change of -$155.73 million (-1.67%) on March 31, 2025.
- Over the past year, BPMC TTM SG&A has dropped by -$9.78 billion (-3199.86%).
Performance
BPMC TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
Selling, General & Administrative Expenses Formula
SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development
BPMC Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +21.7% | +14.7% | -3199.9% |
| 3Y3 Years | +84.0% | +67.9% | -4602.7% |
| 5Y5 Years | +272.7% | +168.7% | -6522.7% |
BPMC Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +84.0% | -0.7% | +66.3% | -61.3% | at low |
| 5Y | 5-Year | at high | +272.7% | -0.7% | +156.3% | -244.7% | at low |
| All-Time | All-Time | at high | +6983.4% | -0.7% | +6567.2% | >-9999.0% | at low |
BPMC Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $95.81M(-0.7%) | $371.52M(+3.4%) |
| Dec 2024 | $359.27M(+21.7%) | $96.45M(+7.3%) | $359.27M(+5.0%) |
| Sep 2024 | - | $89.93M(+0.7%) | $342.14M(+5.9%) |
| Jun 2024 | - | $89.34M(+6.9%) | $322.95M(+5.7%) |
| Mar 2024 | - | $83.56M(+5.3%) | $305.54M(+4.3%) |
| Dec 2023 | $295.14M(+24.3%) | $79.31M(+12.1%) | $292.94M(+5.5%) |
| Sep 2023 | - | $70.74M(-1.7%) | $277.64M(+5.0%) |
| Jun 2023 | - | $71.93M(+1.4%) | $264.51M(+5.3%) |
| Mar 2023 | - | $70.95M(+10.8%) | $251.27M(+5.9%) |
| Dec 2022 | $237.37M(+21.5%) | $64.02M(+11.1%) | $237.37M(+4.3%) |
| Sep 2022 | - | $57.61M(-1.8%) | $227.55M(+3.6%) |
| Jun 2022 | - | $58.69M(+2.9%) | $219.75M(+4.5%) |
| Mar 2022 | - | $57.06M(+5.3%) | $210.35M(+7.7%) |
| Dec 2021 | $195.29M(+23.8%) | $54.20M(+8.8%) | $195.29M(+6.3%) |
| Sep 2021 | - | $49.81M(+1.1%) | $183.63M(+7.3%) |
| Jun 2021 | - | $49.29M(+17.3%) | $171.20M(+4.3%) |
| Mar 2021 | - | $42.00M(-1.3%) | $164.09M(+4.0%) |
| Dec 2020 | $157.74M(+63.7%) | $42.54M(+13.8%) | $157.74M(+7.0%) |
| Sep 2020 | - | $37.38M(-11.4%) | $147.47M(+8.6%) |
| Jun 2020 | - | $42.17M(+18.3%) | $135.74M(+17.5%) |
| Mar 2020 | - | $35.66M(+10.5%) | $115.49M(+19.8%) |
| Dec 2019 | $96.39M | $32.27M(+25.8%) | $96.39M(+23.9%) |
| Sep 2019 | - | $25.65M(+17.0%) | $77.77M(+21.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | $21.92M(+32.4%) | $64.16M(+17.6%) |
| Mar 2019 | - | $16.55M(+21.3%) | $54.57M(+13.9%) |
| Dec 2018 | $47.93M(+71.3%) | $13.64M(+13.3%) | $47.93M(+13.1%) |
| Sep 2018 | - | $12.04M(-2.4%) | $42.38M(+12.4%) |
| Jun 2018 | - | $12.33M(+24.4%) | $37.71M(+17.1%) |
| Mar 2018 | - | $9.91M(+22.5%) | $32.21M(+15.1%) |
| Dec 2017 | $27.99M(+45.6%) | $8.09M(+9.7%) | $27.99M(+12.5%) |
| Sep 2017 | - | $7.38M(+8.0%) | $24.89M(+11.1%) |
| Jun 2017 | - | $6.83M(+20.2%) | $22.40M(+10.6%) |
| Mar 2017 | - | $5.68M(+13.9%) | $20.25M(+5.4%) |
| Dec 2016 | $19.22M(+32.9%) | $4.99M(+2.0%) | $19.22M(+7.7%) |
| Sep 2016 | - | $4.89M(+4.4%) | $17.85M(+3.9%) |
| Jun 2016 | - | $4.69M(+0.9%) | $17.18M(+5.2%) |
| Mar 2016 | - | $4.65M(+28.2%) | $16.33M(+13.0%) |
| Dec 2015 | $14.46M(+83.2%) | $3.62M(-14.2%) | $14.46M(+4.8%) |
| Sep 2015 | - | $4.22M(+9.9%) | $13.79M(+20.0%) |
| Jun 2015 | - | $3.84M(+38.6%) | $11.49M(+26.4%) |
| Mar 2015 | - | $2.77M(-6.5%) | $9.09M(+15.2%) |
| Dec 2014 | $7.89M(+55.6%) | $2.96M(+54.1%) | $7.89M(+60.1%) |
| Sep 2014 | - | $1.92M(+33.7%) | $4.93M(+63.8%) |
| Jun 2014 | - | $1.44M(-8.6%) | $3.01M(+91.4%) |
| Mar 2014 | - | $1.57M | $1.57M |
| Dec 2013 | $5.07M | - | - |
FAQ
- What is Blueprint Medicines Corporation annual SG&A?
- What is the all-time high annual SG&A for Blueprint Medicines Corporation?
- What is Blueprint Medicines Corporation annual SG&A year-on-year change?
- What is Blueprint Medicines Corporation quarterly SG&A?
- What is the all-time high quarterly SG&A for Blueprint Medicines Corporation?
- What is Blueprint Medicines Corporation quarterly SG&A year-on-year change?
- What is Blueprint Medicines Corporation TTM SG&A?
- What is the all-time high TTM SG&A for Blueprint Medicines Corporation?
- What is Blueprint Medicines Corporation TTM SG&A year-on-year change?
What is Blueprint Medicines Corporation annual SG&A?
The current annual SG&A of BPMC is $359.27M
What is the all-time high annual SG&A for Blueprint Medicines Corporation?
Blueprint Medicines Corporation all-time high annual SG&A is $359.27M
What is Blueprint Medicines Corporation annual SG&A year-on-year change?
Over the past year, BPMC annual SG&A has changed by +$64.13M (+21.73%)
What is Blueprint Medicines Corporation quarterly SG&A?
The current quarterly SG&A of BPMC is $95.81M
What is the all-time high quarterly SG&A for Blueprint Medicines Corporation?
Blueprint Medicines Corporation all-time high quarterly SG&A is $96.45M
What is Blueprint Medicines Corporation quarterly SG&A year-on-year change?
Over the past year, BPMC quarterly SG&A has changed by +$12.25M (+14.66%)
What is Blueprint Medicines Corporation TTM SG&A?
The current TTM SG&A of BPMC is -$9.47B
What is the all-time high TTM SG&A for Blueprint Medicines Corporation?
Blueprint Medicines Corporation all-time high TTM SG&A is -$82.21M
What is Blueprint Medicines Corporation TTM SG&A year-on-year change?
Over the past year, BPMC TTM SG&A has changed by -$9.78B (-3199.86%)